{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:23:00Z","timestamp":1794320580257,"version":"4.9.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study aimed to evaluate the gap between guidelines and local clinical practice for diagnosis and treatment of uncomplicated and severe malaria, the patient characteristics, diagnostic approach, treatment, and compliance to standard guideline recommendations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a multicentre, observational study conducted between October 2020 and March 2021 in which patients of all ages with symptoms suggestive of malaria and who visited a healthcare facility were prospectively enrolled in six countries in sub-Saharan Africa (The Democratic Republic of the Congo, Mozambique, Nigeria, Rwanda, The United Republic of Tanzania, and Zambia).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 1001 enrolled patients, 735 (73.4%) patients had confirmed malaria (based on overall judgment by investigator) at baseline (uncomplicated malaria: 598 [81.4%] and severe malaria: 137 [18.6%]). Of the confirmed malaria patients, 533 (72.5%) were administered a malaria rapid diagnostic test. The median age of patients was 11\u00a0years (range: 2\u00a0weeks\u201391\u00a0years) with more patients coming from rural (44.9%) than urban (30.6%) or suburban areas (24.5%). At the community level, 57.8% of patients sought advice or received treatment for malaria and 56.9% of patients took one or more drugs for their illness before coming to the study site. In terms of early access to care, 44.1% of patients came to the study site for initial visit\u2009\u2265\u200948\u00a0h after symptom onset. In patients with uncomplicated malaria, the most prescribed treatments were artemisinin-based combination therapy (ACT; n\u2009=\u2009564 [94.3%]), primarily using artemether-lumefantrine (82.3%), in line with the World Health Organization (WHO) treatment guidelines. In addition, these patients received antipyretics (85.6%) and antibiotics (42.0%). However, in those with severe malaria, only 66 (48.2%) patients received parenteral treatment followed by oral ACT as per WHO guidelines, whereas 62 (45.3%) received parenteral treatment only. After receiving ambulatory care, 88.6% of patients with uncomplicated malaria were discharged and 83.2% of patients with severe malaria were discharged after hospitalization. One patient with uncomplicated malaria having multiple co-morbidities and three patients with severe malaria died.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings of this study suggest that the prescribed treatment in most patients with uncomplicated malaria, but not of those with severe malaria, was in alignment with the WHO recommended guidelines.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12936-023-04650-y","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T08:02:18Z","timestamp":1690272138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa"],"prefix":"10.1186","volume":"22","author":[{"given":"Vito","family":"Baraka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Nhama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Aide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samwel","family":"Gesase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gwasupika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hachizovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geofrey","family":"Makenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Ruchaho","family":"Ntizimira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orikomaba","family":"Obunge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitoto Antoinette","family":"Tshefu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Cousin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nekoye","family":"Otsyula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidkhan","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Risterucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Manyando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"4650_CR1","unstructured":"WHO. World malaria report 2022. Geneva: World Health Organization; 2022. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2022. Accessed 18 July 2023."},{"key":"4650_CR2","unstructured":"WHO. Fact sheet. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/malaria. Accessed 18 July 2023."},{"key":"4650_CR3","unstructured":"WHO. World malaria report 2021. Geneva: World Health Organization; 2021. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021. Accessed 18 July 2023."},{"key":"4650_CR4","unstructured":"WHO. Guidelines for the treatment of malaria, 3rd Edn. Geneva, World Health Organization, 2015. https:\/\/apps.who.int\/iris\/handle\/10665\/162441. Accessed 18 July 2023."},{"key":"4650_CR5","unstructured":"WHO. Guidelines for malaria. Geneva: World Health Organization; 2023. Available at: https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria. Accessed 18 July 2023."},{"key":"4650_CR6","unstructured":"WHO. Information note 2022. The use of rectal artesunate as a pre-referral treatment for severe P. falciparum malaria. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/351187. Accessed 18 July 2023."},{"key":"4650_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12916-022-02541-8","volume":"20","author":"MW Hetzel","year":"2022","unstructured":"Hetzel MW, Okitawutshu J, Tshefu A, Omoluabi E, Awor P, Signorell A, et al. Effectiveness of rectal artesunate as pre-referral treatment for severe malaria in children under 5 years of age: a multi-country observational study. BMC Med. 2022;20:343.","journal-title":"BMC Med"},{"key":"4650_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/tmi.13715","volume":"27","author":"MT Visser","year":"2022","unstructured":"Visser MT, Zonneveld R, Peto TJ, van Vugt M, Dondorp AM, van der Pluijm RW, et al. Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? - A review of guidelines in non-endemic countries. Trop Med Int Health. 2022;27:129\u2013213.","journal-title":"Trop Med Int Health"},{"key":"4650_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2052-3211-7-15","volume":"7","author":"CC Ezenduka","year":"2014","unstructured":"Ezenduka CC, Okonta MJ, Esimone CO. Adherence to treatment guidelines for uncomplicated malaria at two public health facilities in Nigeria; implications for the \u201ctest and treat\u201d policy of malaria case management. J Pharm Policy Pract. 2014;7:15.","journal-title":"J Pharm Policy Pract"},{"key":"4650_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12936-021-03590-9","volume":"20","author":"K Banek","year":"2021","unstructured":"Banek K, Webb EL, Doogue EB, Smith SJ, Chandramohan D, Staedke SG. Factors associated with access and adherence to artemisinin-based combination therapy (ACT) for children under five: a secondary analysis of a national survey in Sierra Leone. Malar J. 2021;20:56.","journal-title":"Malar J"},{"issue":"Suppl 1","key":"4650_CR11","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5588\/pha.17.0047","volume":"8","author":"SV Dlamini","year":"2018","unstructured":"Dlamini SV, Kosgei RJ, Mkhonta N, Zulu Z, Makadzange K, Zhou S, et al. Case management of malaria in Swaziland, 2011\u20132015: on track for elimination? Public Health Action. 2018;8(Suppl 1):S3-7.","journal-title":"Public Health Action"},{"key":"4650_CR12","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1186\/s12913-019-4722-9","volume":"19","author":"MD Argaw","year":"2019","unstructured":"Argaw MD, Mavundla TR, Gidebo KD. Management of uncomplicated malaria in private health facilities in North-West Ethiopia: a clinical audit of current practices. BMC Health Serv Res. 2019;19:932.","journal-title":"BMC Health Serv Res"},{"key":"4650_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12936-019-2670-9","volume":"18","author":"HH Ampadu","year":"2019","unstructured":"Ampadu HH, Asante KP, Bosomprah S, Akakpo S, Hugo P, Gardarsdottir H, et al. Prescribing patterns and compliance with World Health Organization recommendations for the management of severe malaria: a modified cohort event monitoring study in public health facilities in Ghana and Uganda. Malar J. 2019;18:36.","journal-title":"Malar J"},{"key":"4650_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12936-022-04206-6","volume":"21","author":"Y Gindola","year":"2022","unstructured":"Gindola Y, Getahun D, Sugerman D, et al. Adherence to national malaria clinical management and testing guidelines in selected private clinics of Gambela Town, Gambela Region, Ethiopia: a mixed method study. Malar J. 2022;21:164.","journal-title":"Malar J"},{"key":"4650_CR15","unstructured":"Malaria Atlas 2020. https:\/\/data.malariaatlas.org\/trends?year=2020&metricGroup=Malaria&geographicLevel=admin0&metricSubcategory=Pf&metricType=rate&metricName=incidence. Accessed 16 March 2023."},{"key":"4650_CR16","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.pt.2016.11.006","volume":"33","author":"IN Nkumama","year":"2017","unstructured":"Nkumama IN, O\u2019Meara WP, Osier FHA. Changes in malaria epidemiology in Africa and new challenges for elimination. Trends Parasitol. 2017;33:128\u201340.","journal-title":"Trends Parasitol"},{"key":"4650_CR17","doi-asserted-by":"crossref","unstructured":"WHO. Severe Malaria. Trop Med Int Health. 2014, 19 Suppl 1:7\u2013131","DOI":"10.1111\/tmi.12313_2"},{"key":"4650_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017053","volume":"6","author":"J Achan","year":"2011","unstructured":"Achan J, Tibenderana J, Kyabayinze J, Mawejje D, Mugizi H, Rukaaka M, et al. Case management of severe malaria\u2014a forgotten practice: experiences from health facilities in Uganda. PLoS ONE. 2011;6: e17053.","journal-title":"PLoS ONE"},{"key":"4650_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/tropicalmed7070138","volume":"7","author":"NY Ntamabyaliro","year":"2022","unstructured":"Ntamabyaliro NY, Burri C, Lula YN, Nzolo DB, Engo AB, Ngale MA, et al. Determinants of patients\u2019 adherence to malaria treatment in the Democratic Republic of the Congo. Trop Med Infect Dis. 2022;7:138.","journal-title":"Trop Med Infect Dis"},{"key":"4650_CR20","doi-asserted-by":"publisher","first-page":"e00875","DOI":"10.1128\/JCM.00875-19","volume":"57","author":"MM Plucinski","year":"2019","unstructured":"Plucinski MM, Candrinho B, Dimene M, Colborn J, Lu A, Nace D, et al. Assessing performance of HRP2 antigen detection for malaria diagnosis in Mozambique. J Clin Microbiol. 2019;57:e00875-e919.","journal-title":"J Clin Microbiol"},{"key":"4650_CR21","first-page":"126","volume":"21","author":"SS Nundu","year":"2022","unstructured":"Nundu SS, Arima H, Simpson SV, Abel Chitama BA, Munyeku YB, Muyembe JJ, et al. Low prevalence of Plasmodium falciparum parasites lacking pfhrp2\/3 genes among asymptomatic and symptomatic school-age children in Kinshasa. Democratic Republic of Congo Malar J. 2022;21:126.","journal-title":"Democratic Republic of Congo Malar J"},{"key":"4650_CR22","doi-asserted-by":"publisher","first-page":"22979","DOI":"10.1038\/s41598-021-02452-3","volume":"11","author":"JN McCaffery","year":"2021","unstructured":"McCaffery JN, Nace D, Herman C, Singh B, Sompwe EM, Nkoli PM, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions among patients in the DRC enrolled from 2017 to 2018. Sci Rep. 2021;11:22979.","journal-title":"Sci Rep"},{"issue":"Suppl","key":"4650_CR23","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.ijid.2021.12.297","volume":"116","author":"C Oreh","year":"2022","unstructured":"Oreh C, Esimone C, Nworu C, Beshir K. Prevalence of HRP2\/3 gene deletion in Plasmodium falciparum parasites in Abuja. Nigeria Int J Infect Dis. 2022;116(Suppl):S125\u20136.","journal-title":"Nigeria Int J Infect Dis"},{"key":"4650_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3201\/eid2702.191410","volume":"27","author":"C Prosser","year":"2021","unstructured":"Prosser C, Gresty K, Ellis J, Meyer W, Anderson K, Lee R, et al. Plasmodium falciparum histidine-rich protein 2 and 3 gene deletions in strains from Nigeria, Sudan, and South Sudan. Emerg Infect Dis. 2021;27:471\u20139.","journal-title":"Emerg Infect Dis"},{"key":"4650_CR25","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3201\/eid2803.211499","volume":"28","author":"E Rogier","year":"2022","unstructured":"Rogier E, McCaffery JN, Nace D, Svigel S, Assefa A, Hwang J, et al. Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions from persons with symptomatic malaria infection in Ethiopia, Kenya, Madagascar, and Rwanda. Emerg Infect Dis. 2022;28:608\u201316.","journal-title":"Emerg Infect Dis"},{"key":"4650_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12936-020-03459-3","volume":"19","author":"C Bakari","year":"2020","unstructured":"Bakari C, Jones S, Subramaniam G, Mandara C, Chiduo M, Rumisha S, et al. Community-based surveys for Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions in selected regions of mainland Tanzania. Malar J. 2020;19:391.","journal-title":"Malar J"},{"key":"4650_CR27","doi-asserted-by":"publisher","first-page":"842","DOI":"10.4269\/ajtmh.18-0859","volume":"100","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Sikalima J, Parr JB, Chaponda M, Stevenson JC, Thuma PE, et al. The search for Plasmodium falciparum histidine-rich protein 2\/3 deletions in Zambia and implications for Plasmodium falciparum histidine-rich protein 2-based rapid diagnostic tests. Am J Trop Med Hyg. 2019;100:842\u20135.","journal-title":"Am J Trop Med Hyg"},{"key":"4650_CR28","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1186\/s12936-016-1553-6","volume":"15","author":"BI Amboko","year":"2016","unstructured":"Amboko BI, Ayieko P, Ogero M, Julius T, Irimu G, English M. Malaria investigation and treatment of children admitted to county hospitals in western Kenya. Malar J. 2016;15:506.","journal-title":"Malar J"},{"key":"4650_CR29","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s12936-015-0851-8","volume":"14","author":"A Sserwanga","year":"2015","unstructured":"Sserwanga A, Sears D, Kapella BK, Kigozi R, Rubahika D, Staedke SG, et al. Antimalarial prescription practices among children admitted to six public hospitals in Uganda from 2011 to 2013. Malar J. 2015;14:331.","journal-title":"Malar J"},{"key":"4650_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","volume":"20","author":"C Rasmussen","year":"2022","unstructured":"Rasmussen C, Alonso P, Ringwald P. Current and emerging strategies to combat antimalarial resistance. Expert Rev Anti Infect Ther. 2022;20:353\u201372.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"4650_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s44250-023-00028-8","volume":"2","author":"J Hokororo","year":"2023","unstructured":"Hokororo J, Katembo AG, Kinyenje E, Amani D, Ndjovu A, Eliakimu E, et al. Continuity of essential health services amidst COVID-19 pandemic in Tanzania: a pre and post implementation support assessment. Discov Health Systems. 2023;2:19.","journal-title":"Discov Health Systems"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-023-04650-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-023-04650-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T08:02:27Z","timestamp":1690272147000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-023-04650-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4650"],"URL":"https:\/\/doi.org\/10.1186\/s12936-023-04650-y","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"25 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved in all countries by the relevant ethics committees and health authorities required as per local regulations. Written informed consent was obtained before any data collection. Patients aged\u2009<\u200918\u00a0years provided assent with parental\/legal guardian consent as per local guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained as part of the informed consent process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"VB, PA, QB, AN, AD, SG, JG, SH, GM, CN, OO, KT and CM declare no conflict of interest. MC, NO, CR and GS are employed by and own Novartis stock. RP is an employee of Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"215"}}